Genes associated with multiple sclerosis: 15 and counting

References

• Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science278, 1580–1581 (1997).
   PubMed Web of Science ®Google Scholar
• Kere J. Genetics of complex disorders. Biochem. Biophys. Res. Commun.396, 143–146 (2010).
   PubMedGoogle Scholar
• International HapMap Consortium. The International HapMap Project. Nature426(6968), 789–796 (2003).
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Sethupathy P, Junkins HA et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA106, 9362–9367 (2009).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature461, 747–753 (2009).
   PubMed Web of Science ®Google Scholar
• Doolittle TH, Myers RH, Lehrich JR et al. Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology40, 1546–1552 (1990).
   PubMedGoogle Scholar
• Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology28(10), 978–987 (1978).
   PubMedGoogle Scholar
• Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet1(7762), 1240–1241 (1972).
   PubMed Web of Science ®Google Scholar
• Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA. Multiple sclerosis and the HLA-D region: linkage and association studies. J. Neuroimmunol.58, 183–190 (1995).
   PubMed Web of Science ®Google Scholar
• Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens38(1), 1–15 (1991).
   PubMedGoogle Scholar
• The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med.357, 851–862 (2007).
   PubMed Web of Science ®Google Scholar
• Comabella M, Craig DW, Camiña-Tato M et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE3, e3490 (2008).
   PubMed Web of Science ®Google Scholar
• Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet.41, 824–828 (2009).
   PubMed Web of Science ®Google Scholar
• The International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum. Mol. Genet.19, 953–962 (2009).
   PubMedGoogle Scholar
• De Jager PL, Jia X, Wang J et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet.41(7), 776–782 (2009).
   PubMed Web of Science ®Google Scholar
• Oksenberg JR, Baranzini SE. Multiple sclerosis genetics – is the glass half full, or half empty? Nat. Rev. Neurol.6(8), 429–437 (2010).
   PubMed Web of Science ®Google Scholar
• Bush WS, Sawcer SJ, de Jager PL et al. The International Multiple Sclerosis Genetics Consortium (IMSGC). Evidence for polygenic susceptibility to multiple sclerosis – the shape of things to come. Am. J. Hum. Genet.86(4), 621–625 (2010).
   PubMedGoogle Scholar
• The International Multiple Sclerosis Genetics Conssortium (IMSGC). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun.11(5), 397–405 (2010).
   PubMed Web of Science ®Google Scholar
• International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature449(7164), 851–861 (2007).
   PubMed Web of Science ®Google Scholar
• Dixon AL, Liang L, Moffatt MF et al. A genome-wide association study of global gene expression. Nat. Genet.39(10), 1202–1207 (2007).
   PubMed Web of Science ®Google Scholar
• Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol. Ther.116(3), 473–495 (2007).
   PubMed Web of Science ®Google Scholar
• Moratz C, Hayman JR, Gu H, Kehrl JH. Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice. Mol. Cell. Biol.24(13), 5767–5775 (2004).
   PubMed Web of Science ®Google Scholar
• Agenes F, Bosco N, Mascarell L, Fritah S, Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology115(2), 179–188 (2005).
   PubMedGoogle Scholar
• Amundsen SS, Rundberg J, Adamovic S et al. Four novel coeliac disease regions replicated in an association study of a Swedish–Norwegian family cohort. Genes Immun.11(1), 79–86 (2010).
   PubMedGoogle Scholar
• Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in Type 1 diabetes and celiac disease. N. Engl. J. Med.359(26), 2767–2777 (2008).
   PubMed Web of Science ®Google Scholar
• Kang BY, Kim E, Kim TS. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell Signal.17, 665–673 (2005).
   PubMed Web of Science ®Google Scholar
• Hinks A, Martin P, Flynn E et al. Investigation of Type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis. Ann. Rheum. Dis. DOI:10.1136/ard.2009.126938 (2010).
   Google Scholar
• Liu X, Invernizzi P, Lu Y et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet.42(8), 658–660 (2010).
   PubMed Web of Science ®Google Scholar
• Kim Y, McBride J, Kimlin L, Pae EK, Deshpande A, Wong DT. Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality. PLoS ONE4(2), e4518 (2009).
   Google Scholar
• De Jager PL, Chibnik LB, Cui J et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol.8(12), 1111–1119 (2009).
   PubMed Web of Science ®Google Scholar
• Sawcer S, Ban M, Wason J, Dudbridge F. What role for genetics in the prediction of multiple sclerosis? Ann. Neurol.67, 3–10 (2010).
   PubMedGoogle Scholar
• Li B, Leal SM. Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet.5(5), e1000481 (2009).
   Google Scholar
• Siva N. 1,000 genomes project. Nat. Biotechnol.26, 256 (2008).
   PubMedGoogle Scholar
• McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat. Genet.39(7 Suppl.), S37–S42 (2007).
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature444(7118), 444–454 (2006).
   PubMed Web of Science ®Google Scholar
• Grozeva D, Kirov G, Ivanov D et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch. Gen. Psychiatry67(4), 318–327 (2010).
   PubMedGoogle Scholar